Item 5.07. Submission of Matters to a Vote of Security Holders.

On June 9, 2022, Precigen, Inc. (the "Company") held the 2022 Annual Meeting of Shareholders (the "2022 Annual Meeting"). At the 2022 Annual Meeting, the Company's shareholders (i) elected each of the persons listed below as a director for a one-year term, (ii) ratified the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2022, (iii) approved a non-binding advisory resolution approving the compensation of the named executive officers, (iv) approved an amendment to the Precigen, Inc. Amended and Restated 2013 Omnibus Incentive Plan to increase the number of shares of common stock which may be subject to awards thereunder by 10 million and (v) approved an amendment to the Precigen, Inc. 2019 Incentive Plan for Non-Employee Service Providers to increase the number of shares of common stock which may be subject to awards thereunder by 7 million.

Proposal 1 -Election of Directors





                    For         Against     Abstain   Broker Non-Votes
Randal Kirk     117,767,363    5,415,051    151,182      35,897,368
Cesar Alvarez   115,198,628    7,963,075    171,893      35,897,368
Steven Frank    117,514,226    5,649,335    170,035      35,897,368
Vinita Gupta    117,310,332    5,852,594    170,670      35,897,368
Fred Hassan     116,756,913    6,394,061    182,622      35,897,368
Jeffrey Kindler 116,432,490    6,729,277    171,829      35,897,368
Dean Mitchell   102,833,623    20,329,388   170,585      35,897,368
Helen Sabzevari 121,150,581    2,007,507    175,508      35,897,368
Robert Shapiro  117,149,222    6,015,351    169,023      35,897,368
James Turley    115,307,446    7,860,337    165,813      35,897,368

Proposal 2 - Ratification of the Appointment of Deloitte & Touche LLP as the Company's Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2022.





    For      Against  Abstain Broker Non-Votes
154,887,985 4,026,951 316,028        -

Proposal 3 - Non-binding Advisory Resolution Approving the Compensation of the Named Executive Officers.





   For      Against    Abstain  Broker Non-Votes
95,256,025 26,635,629 1,441,942    35,897,368

Proposal 4 - Approval of an amendment to the Precigen, Inc. Amended and Restated 2013 Omnibus Incentive Plan to increase the number of shares of common stock which may be subject to awards thereunder by 10 million.





    For      Against  Abstain Broker Non-Votes
120,552,423 2,643,242 137,931    35,897,368

Proposal 5 - Approval of an amendment to the Precigen, Inc. 2019 Incentive Plan for Non-Employee Service Providers to increase the number of shares of common stock which may be subject to awards thereunder by 7 million.





    For      Against   Abstain Broker Non-Votes
107,552,260 15,615,198 166,138    35,897,368


  Item 9.01. Financial Statements and Exhibits.




(d) Exhibits.



Exhibit
Number     Description
104        Cover Page Interactive Data File - the cover page XBRL tags are
           embedded within the Inline XBRL document

© Edgar Online, source Glimpses